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362a Tuesday, February 10, 2015Cardiomyopathy (HCM) patients abolish the relationship between TnI phos-
phorylation and Ca2þ-sensitivity (uncoupling).
Ca2þ-sensitisers and Ca2þ-desensitisers that act upon troponin alter the Ca2þ-
sensitivity of the myofilament but their relationship with TnI phosphorylation
has never been studied before.
Epigallocatechin-3-gallate (EGCG) is a major extract of green tea and it also
acts as a Ca2þ-desensitiser by binding to Troponin C of the myofilament.
100 mM EGCG decreased Ca2þ-sensitivity of phosphorylated and unphos-
phorylated wild-type thin filaments equally (by 2.1550.45 and 2.8050.48-
fold respectively), retaining the coupling. In contrast, EGCG reduced
Ca2þ-sensitivity of phosphorylated but not unnphosphorylated thin filaments
containing 8 DCM (TPM1 E54K and E40K, TNNC1 G159D, TNNI3 K36Q,
ACTC E361G) and HCM (TPM1 E180G, TNNT2 K280N, ACTC E99K)-
causing mutations. As a result the dependence of Ca2þ-sensitivity upon TnI
phosphorylation of uncoupled mutant thin filaments was restored in every
case. In single myofibrils, EGCG reduced Ca2þ-sensitivity of force and kACT
and also preserved the coupling with wild type and restored coupling with
ACTC E361G mutant myofibrils.
The effect of EGCG demonstrates that it is possible to reverse the pathological
defects in troponin caused by HCM mutations pharmacologically.
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Cardiac contraction is initiated by calcium release from the sarcoplasmic retic-
ulum through channels (ryanodine receptors) that are located near the sarco-
mere ends. Once released, calcium must diffuse towards the sarcomere
center to fully activate the actomyosin contractile system. This physical
arrangement should lead to a spatial calcium gradient and thus non-uniform
contractile activation. We hypothesize that myosin-binding protein C
(MyBP-C), a potent thin filament activator, is localized to the sarcomere center
(C-zone) to mitigate the potential deficit in calcium activation. We used EM
and super-resolution STORM microscopy to visualize the relative positions
of the ryanodine receptors and MyBP-C within the sarcomere. Laser scanning
confocal microscopy of calcium transients in isolated cardiac cells showed that
calcium concentrations at the center of each sarcomere lagged those near the
ends of each sarcomere by as much as 150 nM. The functional impact of this
calcium gradient was determined by examining the sliding of native,
calcium-sensitive actin-thin filament shards over native mouse cardiac
myosin-thick filaments using a TIRFM-based motility assay. The presence of
MyBP-C enhanced the fraction of thin filaments moving within the thick fila-
ment C-zone (pCa50 6.55 0.04 vs 6.45 0.02; p<0.01). 3D EM reconstruc-
tions of native thin filaments suggest this calcium sensitization results from
MyBP-C’s N-terminal domains shifting tropomyosin on the thin filament. Us-
ing an analytic model, we show that MyBP-C residing within the C-zone can
counterbalance differences in calcium activation within the sarcomere during
the early phase of contraction. Thus, MyBP-C’s localization to the C-zone
may function to correct an intrinsic defect in cardiac excitation-contraction
coupling, and any disturbance of MyBP-C localization or function will
contribute to the consequent cardiac pathologies.
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We are investigating the structural dynamics of the calcium pump SERCA, us-
ing a 2-color biosensor and time-resolved FRETmeasurements. SERCAcouples
ATP hydrolysis to Ca2þ transport across the sarcoplasmic or endoplasmic retic-
ulum membrane. Crystal structures suggest that SERCA structure changes
dramatically during active Ca2þ transport, including large movements in thecytoplasmic N andA domains, coupled to more subtle changes in the transmem-
brane domain. However, there is little direct evidence showing how changes in
SERCA structure coordinate, in solution and in cells, with individual steps in the
pump’s ATPase and Ca2þ transport cycles. Furthermore, SERCA is a viable
therapeutic target for a host of diseases_heart failure, diabetes, and cancer_so
it is important to understand how the ATPase and Ca2þ transport cycles are
coupled to changes in the protein’s structure. We are addressing these questions
using a recombinant 2-color SERCAbiosensor (RFP andGFP fused to theN and
A domains) developed byRobia and coworkers for live-cell work. Herewe use it
in isolated membrane fragments to detect changes in SERCA structure in
response to changes in Ca2þ and nucleotide concentrations, both at equilibrium
and in the transient phase after rapid mixing. Our results: 1) reveal critical
changes in the structural-dynamics of the SERCA cytoplasmic domains upon
Ca2þ and nucleotide binding; and 2) suggest a structural-kinetic mechanism
for Ca2þ activation of ATPase cycling with coordinated changes in the position
of the cytoplasmic domains in association with sequential binding of Ca2þ ions
and ATP. 3) These results also allow direct testing of x-ray crystal structure
models in solution and in living cells and inform the discovery of novel SERCA
modulators that directly target the pump’s structural dynamics.
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Normal cardiac contraction and relaxation requires efficient operation of the SR
Ca2þ ATPase, SERCA2a. In failing hearts, decreased SERCA2a expression
and slowed SR Ca2þ reuptake are thought to significantly underlie contractile
dysfunction. We have studied the relationship between decreased SERCA2a
expression and cardiac function using a mouse model of conditional cardiac
Serca2 ablation, the Serca2fl/fl mouse. In this model, Cre activation by tamox-
ifen injection efficiently deletes Serca2 from the heart; four weeks post-
knockout, cardiac SERCA2a protein content is below 5% of normal levels.
Serca2 KO mice survive 7-10 weeks post knockout with only mild in vivo
impairment prior to this time, suggesting that this loss of SERCA2a protein
can be temporarily compensated. We found that isolated SERCA2a KO hearts
retained the ability to respond to ß-adrenergic stimulation ex vivo despite the
loss of most SERCA2a protein. Because the protein regulator of SERCA2a,
phospholamban (PLN), is thought to be a major component of the cardiac ß-
adrenergic response, this finding was unexpected and warranted further detailed
investigation. To identify the mechanism underlying this preserved ß-adren-
ergic response in SERCA2-depleted hearts, we bred Serca2fl/fl and PLN-/-
mice to generate an inducible Serca2 knockout mouse line lacking PLN.
Serca2fl/fl;PLN-/- mice were injected with tamoxifen to induce Serca2 gene
disruption, and isolated hearts from Serca2KO;PLN-/- (‘‘DKO’’) mice were
evaluated by Langendorff perfusion 4-5 weeks after Serca2 knockout. Control
PLN-/- hearts show little response to ß-adrenergic stimulation, and DKO hearts
have impaired contractility under baseline conditions. DKO hearts, however,
show improved systolic and diastolic function when perfused with 50 nM
isoproterenol, indicating that targets of ß-adrenergic signaling beyond PLN
are able to support a significant inotropic and lusitropic response when cardiac
contractility is impaired.We will discuss how these findings support newmech-
anisms underlying heart performance during stress and disease.
Platform: Protein Dynamics and Allostery II
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The HIV-1 envelope (Env) mediates viral entry into host cells. While static im-
ages of Env in unliganded and ligand-bound forms define distinct
